MDS Pharma, Compendia to Develop Cancer PGx Platform

The companies will develop a platform to analyze drug sensitivity and resistance for cancer drugs.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories